A Phase II Study of AT-101 to Overcome Bcl-2-Mediated Resistance to Androgen Deprivation Therapy in Patients with Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer

Mark N. Stein, Maha Hussain, Walter M. Stadler, Glenn Liu, Irina V. Tereshchenko, Susan Goodin, Chandrika Jeyamohan, Howard L. Kaufman, Janice Mehnert, Robert S. Dipaola

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study of AT-101 to Overcome Bcl-2-Mediated Resistance to Androgen Deprivation Therapy in Patients with Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science